桥接同种异体移植物重建优于最大修复治疗慢性巨大肩袖撕裂:前瞻性随机对照试验结果
这项随机对照试验将30例巨大回缩性肩袖撕裂患者分为最大修复组和真皮同种异体移植物桥接重建组,比较2年时WORC指数等结局。桥接重建组术后WORC和DASH评分均优于最大修复组,再撕裂率更低(21% vs 87%,P < .001),肩肱距离维持更好且肩袖关节病进展更少。结论认为桥接重建在患者报告结局、结构愈合和关节病进展方面均优于最大修复。
要点
- 桥接重建组2年WORC和DASH评分均优于最大修复组。
- 桥接重建组再撕裂率21%,最大修复组87%(P < .001)。
- 桥接重建组肩肱距离维持,最大修复组显著下降。
核心结论
- 使用真皮同种异体移植物进行肩袖桥接重建,在术后2年WORC指数上优于最大修复。
- 桥接重建还显示出有利的结构愈合率,并减少向肩袖关节病的进展。
研究设计与样本
- 随机对照试验,证据等级1级;样本量30例(经先验样本量计算确定),为巨大回缩性肩袖撕裂患者。
- 患者随机分配至最大修复组或真皮同种异体移植物桥接重建组。
- 所有患者在术前及术后3个月、6个月、1年、2年完成WORC和DASH问卷;主要结局为2年WORC指数。
- 次要结局包括愈合率、肩袖关节病进展和术后肩肱距离。
- 试验注册于ClinicalTrials.gov(NCT01987973)。
主要发现
- 桥接重建组术后WORC评分为23.93 ± 24.55,最大修复组为53.36 ± 31.93。
- 桥接重建组术后DASH评分为15.77 ± 19.27,最大修复组为34.32 ± 23.31。
- 最大修复组再撕裂率87%,桥接重建组21%(P < .001)。
- 最大修复组向肩袖关节病进展增加。
- 肩肱距离在桥接重建组得以维持,在最大修复组显著下降。
临床怎么用
- 对于慢性、巨大且回缩的肩袖撕裂,可考虑采用真皮同种异体移植物桥接重建而非单纯最大修复。
- 桥接重建可能降低术后再撕裂率并减缓肩袖关节病进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite advances in surgical techniques, the use of maximal repair to treat large or massive rotator cuff tears results in a high retear rate postoperatively. Currently, no randomized controlled trials have compared the outcomes of maximal repair with interposition dermal allograft bridging reconstruction. HYPOTHESIS: We hypothesized that large or massive rotator cuff tendon tears reconstructed using bridging dermal allograft would have better clinical outcomes 2 years postoperatively, as measured using the Western Ontario Rotator Cuff (WORC) index, than would those receiving the current gold standard treatment of debridement and maximal repair alone. We also expected that patients treated via bridging reconstruction using dermal allograft would have fewer postoperative failures as assessed using postoperative magnetic resonance imaging scans. STUDY DESIGN: Randomized controlled trial; Level of evidence 1. METHODS: A sample size of 30 patients (determined using a priori sample size calculation) with massive, retracted rotator cuff tears were randomly allocated to 1 of 2 groups: maximal repair or bridging reconstruction using dermal allograft. All patients completed questionnaires (WORC and Disabilities of the Arm, Shoulder and Hand [DASH]) preoperatively and postoperatively at 3 months, 6 months, 1 year, and 2 years. The primary outcome of this study was the WORC index at 2 years. Secondary outcomes included healing rate, progression of rotator cuff arthropathy, and postoperative acromiohumeral distance in both groups. RESULTS: Patients treated via bridging reconstruction using dermal allograft had better postoperative WORC and DASH scores (23.93 ± 24.55 and 15.77 ± 19.27, respectively) compared with patients who received maximal repair alone (53.36 ± 31.93 and 34.32 ± 23.31, respectively). We also noted increased progression to rotator cuff arthropathy in the maximal repair group with an increased retear rate when compared with the reconstruction group (87% and 21%, respectively; P < .001). The acromiohumeral distance was maintained in the reconstruction group but significantly decreased in the maximal repair group. CONCLUSION: Rotator cuff bridging reconstruction using a dermal allograft demonstrated improved patient-reported outcomes as measured using the WORC index 2 years postoperatively. This technique also showed favorable structural healing rates and decreased progression to arthropathy compared with maximal repair. TRIAL REGISTRATION: ClinicalTrials.gov (NCT01987973).
引用
- Wong I, Sparavalo S, King JP, et al. Bridging Allograft Reconstruction Is Superior to Maximal Repair for the Treatment of Chronic, Massive Rotator Cuff Tears: Results of a Prospective, Randomized Controlled Trial. Am J Sports Med. 2021. PMID: 34494901. doi:10.1177/03635465211039846
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。